GeneDx (WGS) - Sotuvning sof marjinal rentabelligi

Sema4 (WGS) tovar belgisi

Noyob patologiyalarni erta aniqlashga bo'lgan talab sanoat o'sishini rag'batlantirmoqda. GeneDx Holdings Corp. (WGS) yuqori aniqlikdagi butun ekzom sekvensirlash va molekulyar diagnostika orqali daromad keltiradi. Shu bilan birga, biznesning daromadliligi AI joriy etilishi va test hajmlarining kengayishiga bog'liq. Sof marja dinamikasi xarajatlarning samarali nazoratini namoyish etadi va -24.10 ko'rsatkichi kompaniyaning joriy savdo daromadliligi tendentsiyasini aks ettiradi.

genedx.com (WGS) Kompaniya sotuv marjasi: 28.04.2023 - 20.11.2026 davri uchun

GeneDx Corp (WGS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning har tomonlama tahlili:GeneDx Holdings Corp.
Sema4 yetakchi tovari

GeneDx Holdings Corp. (WGS) kompaniyasining genom sekvensirlash sohasidagi yetakchiligi va uning noyob ekzom ma'lumotlar bazasi, sof foyda marjasi bilan aks etganidek, yuqori samaradorlikka olib kelishi kerak. Ushbu ko'rsatkich har bir dollar daromadning qancha qismi foyda ekanligini o'lchaydi va biznesning pessimistik ssenariylar ostida daromadli holatni saqlab qolish qobiliyatini namoyish etadi. Ushbu metrikaning pasayishi moliyaviy barqarorlikning yo'qolishidan dalolat beradi, bu esa aksiyalarni sotib olishni xavfli qiladi.

GeneDx Holdings Corp. kimlar bilan raqobatlashadi

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|Sof marja Ultragenyx RARE|Kompaniya sotuv marjasi Beam Therapeutics (BEAM)|SRPT: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Twist Bioscience|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX